ID

44499

Description

Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00671437

Lien

https://clinicaltrials.gov/show/NCT00671437

Mots-clés

Versions (2)
  1. 18/11/2017 18/11/2017 -
  2. 27/09/2021 27/09/2021 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

27 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Carcinoma, Squamous Cell NCT00671437

Anglais

Eligibility Carcinoma, Squamous Cell NCT00671437

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically proven diagnosis of squamous cell carcinoma of the head and neck (scchn).
Description

Squamous cell carcinoma of the head and neck

Type de données

boolean

Alias
UMLS CUI [1]
C1168401
have either locally recurrent, unresectable, previously irradiated scchn or metastatic scchn, with at least one measurable tumor lesion (by ct scan) and at least one fdg avid (suv >/= 3, >/= 1.5 cm) tumor lesion (by pet/ct).
Description

HEAD NECK CANCER SQUAMOUS CELL RECURRENT Local | Squamous cell carcinoma of the head and neck unresectable | Therapeutic radiology procedure Squamous cell carcinoma of the head and neck | HEAD NECK CANCER SQUAMOUS CELL METASTATIC | Neoplasm Measurable lesion Quantity CT scan | Neoplasm Lesion FDG SUV PET/CT

Type de données

boolean

Alias
UMLS CUI [1,1]
C4524839
UMLS CUI [1,2]
C0205276
UMLS CUI [2,1]
C1168401
UMLS CUI [2,2]
C1519810
UMLS CUI [3,1]
C1522449
UMLS CUI [3,2]
C1168401
UMLS CUI [4]
C0744620
UMLS CUI [5,1]
C0027651
UMLS CUI [5,2]
C1513041
UMLS CUI [5,3]
C1265611
UMLS CUI [5,4]
C0040405
UMLS CUI [6,1]
C0027651
UMLS CUI [6,2]
C0221198
UMLS CUI [6,3]
C0046056
UMLS CUI [6,4]
C2348529
UMLS CUI [6,5]
C1699633
age greater than 18 yrs.
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
ecog performance status of 0-3
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
signed irb approved informed consent.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
clinical history of severe interstitial lung disease (not copd)-as defined by prior pft's with residual volume, total lung capacity, or corrected dlco <30% of predicted. for this study, screening pft's required only if clinically indicated.
Description

Interstitial Lung Disease Severe | Exception COPD | Residual volume Pulmonary function tests | Total Lung Capacity | DLCO Corrected

Type de données

boolean

Alias
UMLS CUI [1,1]
C0206062
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0024117
UMLS CUI [3,1]
C0035190
UMLS CUI [3,2]
C0024119
UMLS CUI [4]
C0040509
UMLS CUI [5,1]
C1516251
UMLS CUI [5,2]
C0205202
prior therapy with an egfr-specific monoclonal antibody (mab) for treatment of metastatic scchn. prior therapy with an egfr-specific mab as part of the definitive treatment of non-metastatic scchn is acceptable if this occurred more than three months previously. prior therapy with an egfr specific tki will not be an exclusion factor.
Description

Monoclonal Antibodies EGFR Specific HEAD NECK CANCER SQUAMOUS CELL METASTATIC

Type de données

boolean

Alias
UMLS CUI [1,1]
C0003250
UMLS CUI [1,2]
C0034802
UMLS CUI [1,3]
C0205369
UMLS CUI [1,4]
C0744620
women of child bearing potential who are current pregnant or breast feeding.
Description

Childbearing Potential Pregnancy | Childbearing Potential Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0032961
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0006147
prior severe (grade 4) infusion reaction to cetuximab.
Description

Infusion reaction Severe Cetuximab | Infusion reaction CTCAE Grades

Type de données

boolean

Alias
UMLS CUI [1,1]
C2368034
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0995188
UMLS CUI [2,1]
C2368034
UMLS CUI [2,2]
C1516728
a serious uncontrolled medical disorder that in the opinion of the investigator would impair the ability of the subject to receive protocol therapy.
Description

Disease Serious Uncontrolled | Protocol Compliance Impaired

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0205318
UMLS CUI [2,1]
C0525058
UMLS CUI [2,2]
C0221099
chemotherapy, radiation therapy, or investigational agents given with the last 14 days.
Description

Chemotherapy | Therapeutic radiology procedure | Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1522449
UMLS CUI [3]
C0013230
uncontrolled diabetes mellitus. (subjects with a fasting blood glucose > 200 at time of pet scanning may need to reschedule to another day after consulting with appropriate physicians.)
Description

Diabetic - poor control | Fasting blood glucose measurement | Positron-Emission Tomography

Type de données

boolean

Alias
UMLS CUI [1]
C0421258
UMLS CUI [2]
C0428568
UMLS CUI [3]
C0032743
Retour au début de la page

Similar models

Eligibility Carcinoma, Squamous Cell NCT00671437

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Squamous cell carcinoma of the head and neck
Item
histologically proven diagnosis of squamous cell carcinoma of the head and neck (scchn).
boolean
C1168401 (UMLS CUI [1])
HEAD NECK CANCER SQUAMOUS CELL RECURRENT Local | Squamous cell carcinoma of the head and neck unresectable | Therapeutic radiology procedure Squamous cell carcinoma of the head and neck | HEAD NECK CANCER SQUAMOUS CELL METASTATIC | Neoplasm Measurable lesion Quantity CT scan | Neoplasm Lesion FDG SUV PET/CT
Item
have either locally recurrent, unresectable, previously irradiated scchn or metastatic scchn, with at least one measurable tumor lesion (by ct scan) and at least one fdg avid (suv >/= 3, >/= 1.5 cm) tumor lesion (by pet/ct).
boolean
C4524839 (UMLS CUI [1,1])
C0205276 (UMLS CUI [1,2])
C1168401 (UMLS CUI [2,1])
C1519810 (UMLS CUI [2,2])
C1522449 (UMLS CUI [3,1])
C1168401 (UMLS CUI [3,2])
C0744620 (UMLS CUI [4])
C0027651 (UMLS CUI [5,1])
C1513041 (UMLS CUI [5,2])
C1265611 (UMLS CUI [5,3])
C0040405 (UMLS CUI [5,4])
C0027651 (UMLS CUI [6,1])
C0221198 (UMLS CUI [6,2])
C0046056 (UMLS CUI [6,3])
C2348529 (UMLS CUI [6,4])
C1699633 (UMLS CUI [6,5])
Age
Item
age greater than 18 yrs.
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status of 0-3
boolean
C1520224 (UMLS CUI [1])
Informed Consent
Item
signed irb approved informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Interstitial Lung Disease Severe | Exception COPD | Residual volume Pulmonary function tests | Total Lung Capacity | DLCO Corrected
Item
clinical history of severe interstitial lung disease (not copd)-as defined by prior pft's with residual volume, total lung capacity, or corrected dlco <30% of predicted. for this study, screening pft's required only if clinically indicated.
boolean
C0206062 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0024117 (UMLS CUI [2,2])
C0035190 (UMLS CUI [3,1])
C0024119 (UMLS CUI [3,2])
C0040509 (UMLS CUI [4])
C1516251 (UMLS CUI [5,1])
C0205202 (UMLS CUI [5,2])
Monoclonal Antibodies EGFR Specific HEAD NECK CANCER SQUAMOUS CELL METASTATIC
Item
prior therapy with an egfr-specific monoclonal antibody (mab) for treatment of metastatic scchn. prior therapy with an egfr-specific mab as part of the definitive treatment of non-metastatic scchn is acceptable if this occurred more than three months previously. prior therapy with an egfr specific tki will not be an exclusion factor.
boolean
C0003250 (UMLS CUI [1,1])
C0034802 (UMLS CUI [1,2])
C0205369 (UMLS CUI [1,3])
C0744620 (UMLS CUI [1,4])
Childbearing Potential Pregnancy | Childbearing Potential Breast Feeding
Item
women of child bearing potential who are current pregnant or breast feeding.
boolean
C3831118 (UMLS CUI [1,1])
C0032961 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0006147 (UMLS CUI [2,2])
Infusion reaction Severe Cetuximab | Infusion reaction CTCAE Grades
Item
prior severe (grade 4) infusion reaction to cetuximab.
boolean
C2368034 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0995188 (UMLS CUI [1,3])
C2368034 (UMLS CUI [2,1])
C1516728 (UMLS CUI [2,2])
Disease Serious Uncontrolled | Protocol Compliance Impaired
Item
a serious uncontrolled medical disorder that in the opinion of the investigator would impair the ability of the subject to receive protocol therapy.
boolean
C0012634 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
C0525058 (UMLS CUI [2,1])
C0221099 (UMLS CUI [2,2])
Chemotherapy | Therapeutic radiology procedure | Investigational New Drugs
Item
chemotherapy, radiation therapy, or investigational agents given with the last 14 days.
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0013230 (UMLS CUI [3])
Diabetic - poor control | Fasting blood glucose measurement | Positron-Emission Tomography
Item
uncontrolled diabetes mellitus. (subjects with a fasting blood glucose > 200 at time of pet scanning may need to reschedule to another day after consulting with appropriate physicians.)
boolean
C0421258 (UMLS CUI [1])
C0428568 (UMLS CUI [2])
C0032743 (UMLS CUI [3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial